Peanut allergy treatments are improving. Options like oral immunotherapy and biologics are helping lower the risk of severe reactions if you’re exposed to peanuts. Living with a peanut allergy ...
Provided a successful phase II outcome, ALK intends to advance the peanut SLIT-tablet into phase III development after which it can be submitted for regulatory approval, expectedly towards the late ...
Her life was one of promise and potential. But during a girls' trip to Budapest in April 2014, everything changed in an instant. Amy was born with a severe nut allergy and she took it very seriously.
Trial expected to complete in 2026. ALK (ALKB:DC / OMX: ALK B) today announced positive interim results from its phase I/II clinical trial (named 'ALLIANCE') for its investigational sublingual ...